Voglibite-M 0.2 Tablet SR

Overview Voglibite-M 0.2 Tablet SR

Diabeva-M 0.2mg Extended-Release tablets are classified as antidiabetic medications. This combination therapy is indicated for adult management of type 2 diabetes. It aids in regulating blood glucose in diabetic patients. Diabeva-M 0.2mg Extended-Release tablets should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continued use is vital, even with well-controlled blood sugar, as discontinuation without medical supervision can lead to elevated glucose levels, potentially resulting in kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan, encompassing dietary modifications, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Possible side effects include nausea, altered taste perception, appetite suppression, gas, abdominal discomfort, diarrhea, and skin rashes; these are generally transient and self-limiting. Persistent or concerning side effects warrant medical consultation. Your physician can provide strategies for managing or treating bothersome side effects. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your doctor before commencing treatment. Pregnant or lactating women must consult their physician before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Voglibite-M 0.2 Tablet SR

Managing Type 2 Diabetes

Major Benefits of Voglibite-M 0.2 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Voglibite-M 0.2mg sustained-release tablet should be administered with a meal.

Common Side effects of Voglibite-M 0.2 Tablet SR:

• Flatulence
• Diarrhea
• Abdominal pain
• Vomiting
• Decreased appetite

How to use Voglibite-M 0.2 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for Voglibite-M 0.2 Tablet SR. Ingest the tablet whole; do not crush, chew, or divide it. This medication should be taken with food.

How Voglibite-M 0.2 Tablet SR works:

Voglibite-M 0.2mg sustained-release tablets contain a dual-action antidiabetic formulation.

What if you forget to take Voglibite-M 0.2 Tablet SR :

Should you forget a Voglibite-M 0.2 Tablet SR dose, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.